logo
Quick Facts
  

Akorn Launches Doxercalciferol Injection - Quick Facts

By RTTNews Staff Writer   ✉   | Published: | Follow Us On Google News

Akorn (AKRX,AKRN.OB) announced it has launched Doxercalciferol Injection Solution, 4 mcg/2 mL in 2mL single-use vials, following approval from the FDA. Akorn said its product is therapeutically equivalent to Hectorol injection, marketed by Genzyme Corporation.

Akorn's Doxercalciferol Injection is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Goldman Sachs Q1 Profit Up 27%, Results Top Estimates
Goldman Sachs Group reported Monday that profit for the first quarter grew 27 percent from last year, reflecting double-digit net revenue growth across all its operating segments. Both earnings per share and quarterly revenues topped analysts' expectations by a large margin.
Tesla Plans Above 10% Cuts In Global Workforce
Electric vehicle maker Tesla Inc. is planning more than 10% reduction in global workforce amid slower EV demand, reports said citing a memo sent by CEO Elon Musk to all employees. According to Musk, duplication of roles as well as the need for cost reductions are the reasons behind the decision. Following the news, Tesla shares were losing around 1.3 percent in pre-market activity on the Nasdaq.
Broccoli Cutlets, Multigrain Bread, Mini Bagels Recalled For Undeclared Allergens
The U.S. Food and Drug Administration announced the recalls of broccoli cutlets, multigrain bread as well as gluten-free cream cheese stuffed mini bagels, citing the presence of various undeclared allergens. New Haven, Connecticut-based Gracie's Kitchen Inc.'s King Kullen broccoli cutlets were called back for undeclared sesame and wheat allergens, while New Britain, Connecticut-based Roly Poly Ba
Global Economics Weekly Update - April 08 - 12, 2024

Inflation data from the U.S. garnered maximum attention this week on the economics front, along with the interest rate decision by the European Central Bank. Read our stories to find out how these two key events are set to influence monetary policy in the months ahead. Other main news from the U.S. were the release of the minutes of the latest Fed policy session and the jobless claims data. Elsewhere, the interest rate decision by the Bank of Canada was also in focus.

View More Videos
Latest Updates on COVID-19
Read More
COVID-19: Drugs in Development
Follow RTT
Copyright © 2024 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap